Neurogene (NGNE) Assets Average (2014 - 2026)

Neurogene has reported Assets Average for 13 years, with the latest figure at $275.9 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average fell 15.25% year-over-year to $275.9 million; the trailing twelve-month figure through Mar 2026 stood at $275.9 million (down 15.25% YoY), and the FY2025 full-year result was $312.2 million, up 11.83% from the prior year.
• Assets Average for Q1 2026 stood at $275.9 million, down from $288.2 million in the prior quarter.
• The five-year high for Assets Average was $325.5 million in Q1 2025, with the low at $91.8 million in Q3 2023.
• Historically, Assets Average has averaged $194.3 million across 5 years, with a median of $172.0 million in 2024.
• Annual changes were most pronounced in 2023 — Assets Average slumped 33.5% — and 2024, when it jumped 101.19%.
• Neurogene's Assets Average stood at $117.9 million in 2022, then jumped by 32.36% to $156.1 million in 2023, then soared by 60.13% to $249.9 million in 2024, then rose by 15.32% to $288.2 million in 2025, then slipped by 4.28% to $275.9 million in 2026.
• The last three Assets Average figures came in at $275.9 million (Q1 2026), $288.2 million (Q4 2025), and $292.6 million (Q3 2025), per Business Quant data.